前海健康(00911)发盈喜 预期2024年股东应占溢利约130万港元 同比扭亏为盈

智通财经
Mar 06, 2025

智通财经APP讯,前海健康(00911)公布,该集团预期2024年股东应占溢利约130万港元,2023年亏损约5270万港元,实现转亏为盈。

公告称,本年度转亏为盈主要是由于以下各项的主要原因包括:(i)由上年度的毛损转为本年度的毛利,约2970万港元,乃由于集团策略性转向销售较高利润的产品组合; (ii)处置子公司获得约5190万港元的一次性收益;及(iii)抵销因电子元件产品的市场价格(特别是半导体)在2024年最后一季度下降,以致集团计提约5400万港元的亏损合约拨备。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10